291 related articles for article (PubMed ID: 26683224)
1. Galiellalactone induces cell cycle arrest and apoptosis through the ATM/ATR pathway in prostate cancer cells.
García V; Lara-Chica M; Cantarero I; Sterner O; Calzado MA; Muñoz E
Oncotarget; 2016 Jan; 7(4):4490-506. PubMed ID: 26683224
[TBL] [Abstract][Full Text] [Related]
2. Ovatodiolide isolated from Anisomeles indica induces cell cycle G2/M arrest and apoptosis via a ROS-dependent ATM/ATR signaling pathways.
Yu CY; Jerry Teng CL; Hung PS; Cheng CC; Hsu SL; Hwang GY; Tzeng YM
Eur J Pharmacol; 2018 Jan; 819():16-29. PubMed ID: 28986085
[TBL] [Abstract][Full Text] [Related]
3. The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer.
Canesin G; Evans-Axelsson S; Hellsten R; Sterner O; Krzyzanowska A; Andersson T; Bjartell A
Eur Urol; 2016 Mar; 69(3):400-4. PubMed ID: 26144873
[TBL] [Abstract][Full Text] [Related]
4. Glionitrin A, a new diketopiperazine disulfide, activates ATM-ATR-Chk1/2 via 53BP1 phosphorylation in DU145 cells and shows antitumor effect in xenograft model.
Kim YJ; Park HB; Yoo JH; Kwon HC; Kim J; Yang HO
Biol Pharm Bull; 2014; 37(3):378-86. PubMed ID: 24583858
[TBL] [Abstract][Full Text] [Related]
5. Berberine, a genotoxic alkaloid, induces ATM-Chk1 mediated G2 arrest in prostate cancer cells.
Wang Y; Liu Q; Liu Z; Li B; Sun Z; Zhou H; Zhang X; Gong Y; Shao C
Mutat Res; 2012 Jun; 734(1-2):20-9. PubMed ID: 22561209
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol analogue (E)-8-acetoxy-2-[2-(3,4-diacetoxyphenyl)ethenyl]-quinazoline induces G₂/M cell cycle arrest through the activation of ATM/ATR in human cervical carcinoma HeLa cells.
Kim JY; Choi HE; Lee HH; Shin JS; Shin DH; Choi JH; Lee YS; Lee KT
Oncol Rep; 2015 May; 33(5):2639-47. PubMed ID: 25812484
[TBL] [Abstract][Full Text] [Related]
7. Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 Signaling.
Karanika S; Karantanos T; Li L; Wang J; Park S; Yang G; Zuo X; Song JH; Maity SN; Manyam GC; Broom B; Aparicio AM; Gallick GE; Troncoso P; Corn PG; Navone N; Zhang W; Li S; Thompson TC
Cell Rep; 2017 Feb; 18(8):1970-1981. PubMed ID: 28228262
[TBL] [Abstract][Full Text] [Related]
8. Riccardin D Exerts Its Antitumor Activity by Inducing DNA Damage in PC-3 Prostate Cancer Cells In Vitro and In Vivo.
Hu Z; Kong F; Si M; Tian K; Yu LX; Young CY; Yuan H; Lou H
PLoS One; 2013; 8(9):e74387. PubMed ID: 24069304
[TBL] [Abstract][Full Text] [Related]
9. ATM/ATR and SMAD3 pathways contribute to 3-indole-induced G₁ arrest in cancer cells and xenograft models.
Huang SM; Lu KT; Wang YC
Anticancer Res; 2011 Jan; 31(1):203-8. PubMed ID: 21273599
[TBL] [Abstract][Full Text] [Related]
10. Oxidative DNA damage is involved in ochratoxin A-induced G2 arrest through ataxia telangiectasia-mutated (ATM) pathways in human gastric epithelium GES-1 cells in vitro.
Cui J; Liu J; Wu S; Wang Y; Shen H; Xing L; Wang J; Yan X; Zhang X
Arch Toxicol; 2013 Oct; 87(10):1829-40. PubMed ID: 23515941
[TBL] [Abstract][Full Text] [Related]
11. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
Zhao P; Chen L; Li LH; Wei ZF; Tong B; Jia YG; Kong LY; Xia YF; Dai Y
BMC Cancer; 2014 Dec; 14():987. PubMed ID: 25527123
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells.
Tyagi A; Singh RP; Agarwal C; Siriwardana S; Sclafani RA; Agarwal R
Carcinogenesis; 2005 Nov; 26(11):1978-87. PubMed ID: 15975956
[TBL] [Abstract][Full Text] [Related]
13. Bortezomib induces G2-M arrest in human colon cancer cells through ROS-inducible phosphorylation of ATM-CHK1.
Hong YS; Hong SW; Kim SM; Jin DH; Shin JS; Yoon DH; Kim KP; Lee JL; Heo DS; Lee JS; Kim TW
Int J Oncol; 2012 Jul; 41(1):76-82. PubMed ID: 22552540
[TBL] [Abstract][Full Text] [Related]
14. Imatinib inhibits inactivation of the ATM/ATR signaling pathway and recovery from adriamycin/doxorubicin-induced DNA damage checkpoint arrest.
Morii M; Fukumoto Y; Kubota S; Yamaguchi N; Nakayama Y; Yamaguchi N
Cell Biol Int; 2015 Aug; 39(8):923-32. PubMed ID: 25790472
[TBL] [Abstract][Full Text] [Related]
15. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
Hellsten R; Johansson M; Dahlman A; Dizeyi N; Sterner O; Bjartell A
Prostate; 2008 Feb; 68(3):269-80. PubMed ID: 18163422
[TBL] [Abstract][Full Text] [Related]
16. Genistein induces G2/M cell cycle arrest and apoptosis of human ovarian cancer cells via activation of DNA damage checkpoint pathways.
Ouyang G; Yao L; Ruan K; Song G; Mao Y; Bao S
Cell Biol Int; 2009 Dec; 33(12):1237-44. PubMed ID: 19732843
[TBL] [Abstract][Full Text] [Related]
17. Cucurbitacin B induced ATM-mediated DNA damage causes G2/M cell cycle arrest in a ROS-dependent manner.
Guo J; Wu G; Bao J; Hao W; Lu J; Chen X
PLoS One; 2014; 9(2):e88140. PubMed ID: 24505404
[TBL] [Abstract][Full Text] [Related]
18. Mangrove dolabrane-type of diterpenes tagalsins suppresses tumor growth via ROS-mediated apoptosis and ATM/ATR-Chk1/Chk2-regulated cell cycle arrest.
Neumann J; Yang Y; Köhler R; Giaisi M; Witzens-Harig M; Liu D; Krammer PH; Lin W; Li-Weber M
Int J Cancer; 2015 Dec; 137(11):2739-48. PubMed ID: 26061604
[TBL] [Abstract][Full Text] [Related]
19. Jaridonin-induced G2/M phase arrest in human esophageal cancer cells is caused by reactive oxygen species-dependent Cdc2-tyr15 phosphorylation via ATM-Chk1/2-Cdc25C pathway.
Ma YC; Su N; Shi XJ; Zhao W; Ke Y; Zi X; Zhao NM; Qin YH; Zhao HW; Liu HM
Toxicol Appl Pharmacol; 2015 Jan; 282(2):227-36. PubMed ID: 25450480
[TBL] [Abstract][Full Text] [Related]
20. SWATH proteomic profiling of prostate cancer cells identifies NUSAP1 as a potential molecular target for Galiellalactone.
Garrido-Rodríguez M; Ortea I; Calzado MA; Muñoz E; García V
J Proteomics; 2019 Feb; 193():217-229. PubMed ID: 30626528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
